Get in Touch
0
0

Insights Blog

Explore our thought leadership insights, as life science technologies evolve and accelerate.
Filters
Reset All
Search
Industries
Insight Type
Topics
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Newsletter Update
Pharma & Biotech
Digital Health | Q3 Update
While the economic slump looks as though it may continue through the final quarter of 2022, we will continue to stay abreast of emerging developments in digital health.
October 5, 2022
Newsletter Update
Pharma & Biotech
Digital Health | Q3 Update
While the economic slump looks as though it may continue through the final quarter of 2022, we will continue to stay abreast of emerging developments in digital health.
October 5, 2022
Health Technology Market
Medical Devices
Digital Health
Blog Article
Pharma & Biotech
IGF 2022: DeciBio Highlights – Illumina delivers
Read about our take on Illumina's new line of product launched at its inaugural Illumina Genomics Forum (IGF) last week.
October 3, 2022
Blog Article
Pharma & Biotech
IGF 2022: DeciBio Highlights – Illumina delivers
Read about our take on Illumina's new line of product launched at its inaugural Illumina Genomics Forum (IGF) last week.
October 3, 2022
Next-Generation Therapeutics
DeciBio Q&A
Clinical Diagnostics
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022
DeciBio Q&A
Clinical Diagnostics
Explainable, Unbiased AI and Computational Systems Pathology: Q&A with Dusty Majumdar and Chakra Chennubhotla of SpIntellx
DeciBio interviews Dusty Majumdar and Chakra Chennubhotla, CEO and CTO at SpIntellx.
September 22, 2022
Digital Pathology
Blog Article
Clinical Diagnostics
Oncologist Perspectives on the Most Exciting Advancements in Precision Medicine
DeciBio conducted a pulse survey with 8 U.S. oncologists to ascertain what precision oncology advancements excite them the most.
September 21, 2022
Blog Article
Clinical Diagnostics
Oncologist Perspectives on the Most Exciting Advancements in Precision Medicine
DeciBio conducted a pulse survey with 8 U.S. oncologists to ascertain what precision oncology advancements excite them the most.
September 21, 2022
Precision Medicine
Immuno-Oncology
Next-Generation Therapeutics
DeciBio Q&A
Clinical Diagnostics
Digital Pathology for Biomarker Development: Decibio’s Q&A with Chan-Young Ock of Lunit
Decibio interviews Dr. Chan-Young Ock of recently IPO’d digital pathology firm, Lunit.
September 21, 2022
DeciBio Q&A
Clinical Diagnostics
Digital Pathology for Biomarker Development: Decibio’s Q&A with Chan-Young Ock of Lunit
Decibio interviews Dr. Chan-Young Ock of recently IPO’d digital pathology firm, Lunit.
September 21, 2022
Clinical Diagnostics
Research Tools
AI / Machine Learning
Digital Pathology
Immuno-Oncology
In The Press
Pharma & Biotech
Mark a Course for the Future – Biomarkers in Cancer Immunotherapy
Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.
September 15, 2022
In The Press
Pharma & Biotech
Mark a Course for the Future – Biomarkers in Cancer Immunotherapy
Here we explore how biomarkers are driving the immuno-oncology landscape. We dive into cutting-edge biomarker research and the challenges facing the field.
September 15, 2022
Biomarkers
Immuno-Oncology
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions